Rogers Ashton L, Burnett Alexander, Eckard Peter, Farsi Soroush, Gardner James R, Dornhoffer John L, Saadi Robert A
Department of Otolaryngology-Head and Neck Surgery University of Arkansas for Medical Sciences Little Rock Arkansas USA.
Laryngoscope Investig Otolaryngol. 2025 May 19;10(3):e70162. doi: 10.1002/lio2.70162. eCollection 2025 Jun.
Spontaneous retropharyngeal hematoma (SRH) is a rare and potentially life-threatening condition with the potential to cause acute airway obstruction. This review aims to describe the presentation, predisposing factors, and management of SRH cases to better understand the clinical course and guide strategies for identifying and managing this condition.
PubMed, Embase, and Web of Science.
Databases were queried for articles from inception to February 2025. Study protocols adhered to the PRISMA guidelines. Case reports and series describing SRH were included. Study validity was assessed using the Joanna Briggs institute's critical appraisal tools and AMSTAR 2 criteria.
Seventeen cases (eight males and nine females) met inclusion criteria for analysis. On average, they presented at 59.7 (± 21.4) years old with sudden dysphagia (76.5%), anterior neck swelling (64.7%), neck pain (58.8%), and dysphonia (41.2%). Notably, 4 (23.5%) patients were taking an antithrombotic medication. Diagnosis was made using CT neck in 82.4% of cases. While 12 (70.6%) cases were managed medically, 5 (29.4%) received surgical intervention, and 6 (35.3%) required intubation. 16 (94.1%) cases had complete resolution within an average of 27.9 (± 24.8) days, and one patient (5.9%) died from airway compromise.
SRH is a rare condition that presents with nonspecific dysphagia or neck discomfort. Antithrombotic medications may serve as a risk factor. Most patients will not require operative management, but close observation is needed as progression to fatal airway compromise has been documented.
自发性咽后血肿(SRH)是一种罕见且可能危及生命的疾病,有可能导致急性气道梗阻。本综述旨在描述SRH病例的表现、诱发因素及治疗方法,以更好地了解其临床病程,并指导识别和管理该疾病的策略。
PubMed、Embase和科学网。
检索数据库中从建库至2025年2月的文章。研究方案遵循PRISMA指南。纳入描述SRH的病例报告和系列研究。使用乔安娜·布里格斯研究所的批判性评价工具和AMSTAR 2标准评估研究的有效性。
17例(8例男性和9例女性)符合纳入分析标准。他们平均发病年龄为59.7(±21.4)岁,主要表现为突发吞咽困难(76.5%)、颈部前方肿胀(64.7%)、颈部疼痛(58.8%)和声音嘶哑(41.2%)。值得注意的是,4例(23.5%)患者正在服用抗血栓药物。82.4%的病例通过颈部CT确诊。12例(70.6%)病例接受药物治疗,5例(29.4%)接受手术干预,6例(35.3%)需要插管。16例(94.1%)病例在平均27.9(±24.8)天内完全康复,1例患者(5.9%)死于气道受压。
SRH是一种罕见疾病,表现为非特异性吞咽困难或颈部不适。抗血栓药物可能是一个危险因素。大多数患者不需要手术治疗,但由于已有致命气道受压进展的记录,需要密切观察。